CFTR and cystic fibrosis-related diabetes: In fact, the recent discoveries of novel therapeutic approaches based on CFTR corrector/modulator drugs and the hypotheses related to other possible strategies that increase the level and/or function of other proteins involved in CFRD pathogenesis, to be used early in young patients, have led to a new scenario in the treatment and prevention of diabetes in CF.